Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study

SIMPLE SUMMARY: Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared, especially in patients with locally advanced PC (LAPC). By carefully selecting patients, it is likely these two regimens lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Williet, Nicolas, Petrillo, Angelica, Roth, Gaël, Ghidini, Michele, Petrova, Mila, Forestier, Julien, Lopez, Anthony, Thoor, Audrey, Weislinger, Lucie, De Vita, Ferdinando, Taieb, Julien, Phelip, Jean Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200096/
https://www.ncbi.nlm.nih.gov/pubmed/34199796
http://dx.doi.org/10.3390/cancers13112797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200096/
https://www.ncbi.nlm.nih.gov/pubmed/34199796
http://dx.doi.org/10.3390/cancers13112797

Ejemplares similares